Log in
Enquire now
Bio-Path Holdings

Bio-Path Holdings

Bio-Path Holdings is an antisense DNA therapeutics founded in 2011 by Peter Nielsen.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/bio-path-holdings
B2X
B2B
B2B
0
Board of Directors
‌
Douglas P. Morris
0
CAGE Code
50UV4
0
CEO
Peter Nielsen
Peter Nielsen
0
CFO
Peter Nielsen
Peter Nielsen
0
CIK Number
1,133,818
0
Legal Name
Bio-Path Holdings, Inc.
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...holdings
DUNS Number
809721751
0
Facebook URL
@pages/Bio-Path-Holdings-INC/134873373300849
Founded Date
2011
Founder
Ana Tari Ashizawa
Ana Tari Ashizawa
0
Peter Nielsen
Peter Nielsen
0
Full Address
Bio-Path Holdings, Inc. 4710 Bellaire Blvd, Suite 210 Bellaire, TX 77401
0
Industry
Engineering
Engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Healthcare
Healthcare
Biology
Biology
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
IRS Number
870,652,870
0
Latest Funding Round Date
December 22, 2010
Location
Bellaire, Texas
Bellaire, Texas
0
NAICS Code
325,412
0
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
5
Phone Number
0
Pitchbook URL
pitchbook.com/profiles.../41557-51
Place of Incorporation
Delaware
Delaware
0
Previous Name
OGDEN GOLF CO CORP
0
SIC Code
2,834
0
Exchange
Nasdaq
Nasdaq
0
Stock Symbol
BPTH
0
Ticker Symbol
BPTH
Total Funding Amount (USD)
741,000
Twitter URL
@biopathholdings
Official Website
biopathholdings.com
Wellfound ID
bio-path-holdings

Find more companies like Bio-Path Holdings

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.